MOPEAD – Models of Patient Engagement for Alzheimer’s Disease
Novel Research to improve timely diagnosis of Alzheimer’s disease (AD) through citizen participation.
Today, a significant proportion of people with dementia are not diagnosed and, consequently, do not have access to available care and treatment. This also deprives them of having the opportunity to participate in clinical trials at early stages of the disease if these are available. The aim of MOPEAD is to contribute to redress the situation: the project will assess different Patient Engagement models across Europe that will help identify subjects with mild cognitive impairment and mild AD dementia (an early stage of the disease in which patients experience cognitive impairment and problems but are still autonomous). MOPEAD has the potential to contribute to move the AD Environment towards earlier diagnosis to improve identification of appropriate patients for disease modifying therapies.